University of Kansas Medical Center
Dr. Joel Mermis is an associate professor of medicine, board certified in pulmonary and critical care medicine, having joined the faculty at the University of Kansas Medical Center (KUMC) in 2010. He has been director of the adult cystic fibrosis program at KUMC since 2011. In 2012 Dr. Mermis became director of the Cystic Fibrosis Foundation Therapeutic Development Network (TDN) clinical research program at KUMC. Since joining the TDN in 2012, the cystic fibrosis clinical research program at KUMC has rapidly grown to become a top performing center. During this time, Dr. Mermis has been the principal investigator for various observational and therapeutic phase one, two, and three clinical trials including various investigator-initiated research projects with focus on cystic fibrosis outcomes and quality improvement.
Saturday, November 5, 2022
3:30 PM – 5:30 PM ET